Type 2 & other diabetes

Magnetic resonance study of visceral, subcutaneous, liver and pancreas fat changes after 12 weeks intermittent fasting in obese participants with prediabetes

Diabetes Res Clin PractPublished Secondary analysis of a randomised controlled trial

Authors' conclusion

Overall weight loss was correlated with fat loss from subcutaneous depots. Losses from different fat depots did not correlate with changes in HbA1c or differ by probiotic supplementation, ethnicity or sex.

Study context

Population
Obese participants with prediabetes on 5:2 intermittent fastingMRI at baseline and 12 weeks
Participants
24 participants
Comparison
Daily probiotic vs placebo during 5:2 intermittent fasting
Methodological detailsmagnetic resonance imaging study, placebo-controlled, randomized 1:1
  • Magnetic resonance imaging study
  • Placebo-controlled
  • Randomized 1:1

Primary result

As reported in the abstract

Fat depot changes with intermittent fasting (all participants) · baseline to 12 weeks

Subcutaneous fat (%) changed from baseline to 12 weeks (p < 0.001)

35.9 ± 3.1 to 34.4 ± 3.2

Visceral fat (%) changed from baseline to 12 weeks (p < 0.001)

15.8 ± 1.3 to 14.8 ± 1.2

Liver fat (%) changed from baseline to 12 weeks (p < 0.001)

8.7 ± 0.8 to 7.5 ± 0.7

Pancreatic fat (%) changed from baseline to 12 weeks (p < 0.001)

7.7 ± 0.5 to 6.5 ± 0.5

Further findings

Changes in weight, HbA1c, SAT, VAT, LF and PF, probiotic vs placebo · 12 weeks

Changes did not differ significantly between probiotic and placebo

Original publication

Magnetic resonance study of visceral, subcutaneous, liver and pancreas fat changes after 12 weeks intermittent fasting in obese participants with prediabetes. Diabetes Res Clin Pract. Published 12 June 2023. doi:10.1016/j.diabres.2023.110775

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.